Previous Article | Next Article 
Journal of Clinical Microbiology, July 2004, p. 2961-2965, Vol. 42, No. 7
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.7.2961-2965.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Performance of Commercially Available Enzyme Immunoassays for Detection of Antibodies against Herpes Simplex Virus Type 2 in African Populations
Eddy Van Dyck,1* Anne Buvé,1 Helen A. Weiss,2 Judith R. Glynn,2 David W. G. Brown,3 Bénédicte De Deken,1 John Parry,3 and Richard J. Hayes2
Institute of Tropical Medicine, Antwerp, Belgium,1
London School of Hygiene and Tropical Medicine,2
Central Public Health Laboratory, London, United Kingdom3
Received 11 August 2003/
Returned for modification 19 January 2004/
Accepted 27 March 2004
Data are accumulating on the performance of enzyme immunoassays (EIAs) for the detection of herpes simplex virus type 2 (HSV-2) infection in North America and Europe, but little is known about their performance in other populations. Nine test kits were evaluated with 330 serum samples from sub-Saharan Africa. The tests were first compared to the monoclonal antibody (MAb) EIA (Central Public Health Laboratory, London, United Kingdom). Samples that gave discordant results in the MAb EIA and in the three tests that performed best compared to the MAb EIA were tested by Western blotting (University of Washington, Seattle). A random sample of concordant samples was also tested, and the sensitivities and specificities of the different tests were calculated, taking into account this sampling strategy. The sensitivities of the tests ranged from 86 to 100%; the specificities ranged from 47 to 99%. The tests that performed best were the Gull Premier EIA (sensitivity, 86.3%; specificity, 97.6%) and the Kalon Biological (sensitivity, 92.3%; specificity, 97.7%) and Biokit (sensitivity, 86.7%; specificity, 92.6%) tests. It cannot be assumed that enzyme immunoassays for the detection of HSV-2 infection that perform well in industrialized countries will perform equally well in other populations.
* Corresponding author. Mailing address: Institute of Tropical Medicine, Nationalestraat 155, B-2000 Antwerp, Belgium. Phone: 32-3-247-65-33. Fax: 32-3-247-65-32. E-mail:
abuve{at}itg.be.
Journal of Clinical Microbiology, July 2004, p. 2961-2965, Vol. 42, No. 7
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.7.2961-2965.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Smith, J S, Bailey, R C, Westreich, D J, Maclean, I, Agot, K, Ndinya-Achola, J O, Hogrefe, W, Morrow, R A, Moses, S
(2009). Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing. Sex. Transm. Infect.
85: 92-96
[Abstract]
[Full Text]
-
Glynn, J R, Crampin, A C, Ngwira, B M M, Ndhlovu, R, Mwanyongo, O, Fine, P E M
(2008). Herpes simplex virus type 2 trends in relation to the HIV epidemic in northern Malawi. Sex. Transm. Infect.
84: 356-360
[Abstract]
[Full Text]
-
Ngo, T. D., Laeyendecker, O., Morrow, R. A., Lai, S., Quinn, T. C.
(2008). Comparison of Three Commercial Immunoassays for Detection of Herpes Simplex Virus Type 2 Antibodies in Commercial Sex Workers in Yunnan Province, China. CVI
15: 1301-1303
[Abstract]
[Full Text]
-
Benzaken, A S, Sabido, M, Galban, E G, Pedroza, V, Vasquez, F, Araujo, A, Peeling, R W, Mayaud, P
(2008). Field evaluation of the performance and testing costs of a rapid point-of-care test for syphilis in a red-light district of Manaus, Brazil. Sex. Transm. Infect.
84: 297-302
[Abstract]
[Full Text]
-
LeGoff, J., Mayaud, P., Gresenguet, G., Weiss, H. A., Nzambi, K., Frost, E., Pepin, J., Belec, L., and the ANRS 12-12 Study Group,
(2008). Performance of HerpeSelect and Kalon Assays in Detection of Antibodies to Herpes Simplex Virus Type 2. J. Clin. Microbiol.
46: 1914-1918
[Abstract]
[Full Text]
-
Paz-Bailey, G, Ramaswamy, M, Hawkes, S J, Geretti, A M
(2008). Herpes simplex virus type 2: epidemiology and management options in developing countries. Postgrad. Med. J.
84: 299-306
[Abstract]
[Full Text]
-
Gamiel, J. L., Tobian, A. A. R., Laeyendecker, O. B., Reynolds, S. J., Morrow, R. A., Serwadda, D., Gray, R. H., Quinn, T. C.
(2008). Improved Performance of Enzyme-Linked Immunosorbent Assays and the Effect of Human Immunodeficiency Virus Coinfection on the Serologic Detection of Herpes Simplex Virus Type 2 in Rakai, Uganda. CVI
15: 888-890
[Abstract]
[Full Text]
-
Diawara, S., Kane, C. T., Legoff, J., Gaye, A. G., Mboup, S., Belec, L.
(2008). Low seroprevalence of herpes simplex virus type 2 among pregnant women in Senegal. Int J STD AIDS
19: 159-160
[Abstract]
[Full Text]
-
Ngo, T. D., Laeyendecker, O., La, H., Hogrefe, W., Morrow, R. A., Quinn, T. C.
(2008). Use of Commercial Enzyme Immunoassays To Detect Antibodies to the Herpes Simplex Virus Type 2 Glycoprotein G in a Low-Risk Population in Hanoi, Vietnam. CVI
15: 382-384
[Abstract]
[Full Text]
-
Nagot, N., Ouedraogo, A., Defer, M.-C., Vallo, R., Mayaud, P., Van de Perre, P.
(2007). Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex. Transm. Infect.
83: 365-368
[Abstract]
[Full Text]
-
Nascimento, M. C., Ferreira, S., Sabino, E., Hamilton, I., Parry, J., Pannuti, C. S., Mayaud, P.
(2007). Performance of the HerpeSelect (Focus) and Kalon Enzyme-Linked Immunosorbent Assays for Detection of Antibodies against Herpes Simplex Virus Type 2 by Use of Monoclonal Antibody-Blocking Enzyme Immunoassay and Clinicovirological Reference Standards in Brazil. J. Clin. Microbiol.
45: 2309-2311
[Abstract]
[Full Text]
-
Nagot, N., Ouedraogo, A., Foulongne, V., Konate, I., Weiss, H. A., Vergne, L., Defer, M.-C., Djagbare, D., Sanon, A., Andonaba, J.-B., Becquart, P., Segondy, M., Vallo, R., Sawadogo, A., Van de Perre, P., Mayaud, P., the ANRS 1285 Study Group,
(2007). Reduction of HIV-1 RNA Levels with Therapy to Suppress Herpes Simplex Virus. NEJM
356: 790-799
[Abstract]
[Full Text]
-
Paz-Bailey, G, Ramaswamy, M, Hawkes, S J, Geretti, A M
(2007). Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex. Transm. Infect.
83: 16-22
[Abstract]
[Full Text]
-
Geretti, A M
(2006). Genital herpes. Sex. Transm. Infect.
82: iv31-iv34
[Full Text]
-
Gorander, S., Mbwana, J., Lyamuya, E., Lagergard, T., Liljeqvist, J.-A.
(2006). Mature Glycoprotein G Presents High Performance in Diagnosing Herpes Simplex Virus Type 2 Infection in Sera of Different Tanzanian Cohorts. CVI
13: 633-639
[Abstract]
[Full Text]
-
Weiss, H A, Thomas, S L, Munabi, S K, Hayes, R J
(2006). Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis.. Sex. Transm. Infect.
82: 101-110
[Abstract]
[Full Text]